QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
Log in

Analysts Aren't Bullish on Factset Research Systems Stock…Is it a Contrarian Buy?

Wednesday, September 23, 2020 | MarketBeat Staff
Analysts Arent Bullish on Factset Research Systems Stock…Is it a Contrarian Buy?

Factset Research Systems (NYSE:FDS) may be one of the most under-loved U.S. mid-cap stocks—and this could be a good thing. The maker of analytical software for investment professionals has some of the best growth metrics in the information services space, although you wouldn't know it by the Street's opinions of its stock.

Covered by 14 analysts, Factset does not presently have a single buy rating. Five analysts call it a sell while the remainder have hold ratings. The highest price target of $315 is 6% below the current share price.

Is the consensus opinion consistent with the company's fundamentals, or is Factset a contrarian buy opportunity? As the company gets set to report fourth-quarter performance pre-market on September 24th, better than expected results could really catch the market off guard.

Why is the Street Cautious on Factset?

Last quarter, Factset fell short on revenues but handily topped the consensus earnings estimate. Despite the 17% bottom line beat, the market grew concerned about the company's heightened level of investments,a trend that is expected to persist.

Factset is investing in its next-generation cloud-based platform to evolve with where financial technology is heading. Amid a digital transformation in the industry, Factset is pouring significant dollars into flexible, mobile technology and producing differentiated, personalized client content.

These are indeed big-time investments. But sometimes you have to spend money to make money. The market appears shortsighted in this regard.

Factset has also been active on the acquisition front, which has been a major part of its growth. This not only comes with the cost of buying the new companies, but with integration expenses and risks. In connection with the acquisitions, the debt load has increased beyond the cash balance to $574 million. With so many moving parts now under its wing, Factset has become somewhat of a 'prove it' story.

Complicating matters, competition has heated up in the financial market data and services space. A bevy of fintech startups threaten to change the way investment firms do research and manage their databases. This has placed competitive and pricing pressures on Factset.

However, somewhat lost in the recent report was a string of positive developments in the cost column. With the offices of most customers and prospects closed due to the pandemic, travel and entertainment expenses were down. This is a trend that will likely continue as the financial services sector shifts towards more virtually based client and vendor meetings. And with many Factset employees working remotely, productivity improved. Factset's staff addition strategy geared towards the lower-cost parts of the world also bodes well for expenses.

What Should We Look for When Factset Reports?

For Q4 analysts are looking for EPS of $2.54 which would represent a 3% year-over-year earnings decline. Given a partial return to business normalcy and the improvements on the expense side of the ledger, its conceivable that Factset ekes out flat earnings if not low single-digit growth. This would stretch its earnings-beat streak to seven quarters. And depending on what the market chooses to focus on, it could also spark a rally in the stock and upward estimate revisions for fiscal 2021.

Factset's international growth metrics will also be under the microscope. International revenues accounted for about 38% of total revenue last year and are growing faster than the domestic business.

Results in the Asia Pacific region will be watched particularly closely. Although the APAC region comprises around 10% of revenue, it is the company's fastest-growing region. Factset's Shanghai office caters to the region's swelling ranks of investment managers and will be a key component of future growth.

Should Investors Buy Factset?

Despite the subdued analyst sentiment toward Factset, the company has a lot in its favor. For one, it’s still very much a leading provider of data and analytic solutions for the global investment community. Its high-end offerings command premium subscription rates and allow the company to increase prices.

Prior to this year, when virtually all businesses have slowed due to the economic environment, Factset's earnings growth was accelerating from 14.2% in 2017 to 16.7% in 2018 to 17.2% in 2019.

In 2020, annual subscription value (ASV), a key measure of Factset's recurring revenue stream, has been on the rise due to broad-based growth in the Wealth, Research, and International segments.

The underlying trends in client count and user count are also favorable. The number of financial services companies that spend at least $10,000 on annual Factset subscription services was up 5% to over 5,700 last quarter.

Client retention rates are hovering around 90% even though it operates in an increasingly competitive space marked by a continual wave of new products.

Given Factset's extensive global network and opportunities to grow both geographically and from new product launches, it is well positioned to benefit from growth in the investment analytics market.

Once the investments in its platforms begin to bear fruit, analysts may start to play catch-up. So, any near-term weakness in Factset stock related to overall market conditions or the company's ramp in investments may be a good entry point for investors.

 

 

Companies Mentioned in This Article

CompanyBeat the Market™ RankCurrent PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
FactSet Research Systems (FDS)1.3$333.30-0.2%0.92%34.54Hold$285.08
Compare These Stocks  Add These Stocks to My Watchlist 

12 Marijuana Stocks to Buy Now

There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

View the "12 Marijuana Stocks to Buy Now".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.